Search
Lirimilast
go.drugbank.com/drugs/DB20727ExperimentalLirimilast is a small molecule drug. The usage of the INN stem '-milast' in the name indicates that Lirimilast is a Phosphodiesterase-4 (PDE4) inhibitor.
Cloxacepride
go.drugbank.com/drugs/DB21428ExperimentalCloxacepride is a small molecule drug. The usage of the INN stem '-pride' in the name indicates that Cloxacepride is a sulpiride derivative and analogue.
Bofutrelvir
go.drugbank.com/drugs/DB21501ExperimentalBofutrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Bofutrelvir is a antiviral 3CL protease inhibitor.
Ulecaciclib
go.drugbank.com/drugs/DB21595ExperimentalUlecaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Ulecaciclib is a cyclin dependant kinase inhibitor.
Eciruciclib
go.drugbank.com/drugs/DB21597ExperimentalEciruciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Eciruciclib is a cyclin dependant kinase inhibitor.
Zevotrelvir
go.drugbank.com/drugs/DB21638ExperimentalZevotrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Zevotrelvir is a antiviral 3CL protease inhibitor.
Orenasitecan
go.drugbank.com/drugs/DB21718ExperimentalOrenasitecan is a small molecule drug. The usage of the INN stem '-tecan' in the name indicates that Orenasitecan is a antineoplastic, topoisomerase I inhibitor.
Mocaciclib
go.drugbank.com/drugs/DB21730ExperimentalMocaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Mocaciclib is a cyclin dependant kinase inhibitor.
OT-730
go.drugbank.com/drugs/DB16112InvestigationalOT-730 is under investigation in clinical trial NCT00753168 (Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma).
COVID19 s-vax loaded autologous dendritic cell vaccine
go.drugbank.com/drugs/DB15814ExperimentalThe rationale is that loading a DC cell with SARS-Cov-2 antigens and administering it as a vaccine can induce a more prolific immune response. … DC-based vaccines are currently used in cancer therapeutics, and are being tested for COVID-19.